NASDAQ · LIMNWHealthcareBiotechnology

Liminatus Pharma, Inc. Warrants financials

$0.0599+37.07%
Close Sep 23, 2026 · split-adjusted
Liminatus Pharma, Inc. Warrants has no annual financial statements on file. Funds and some foreign issuers do not file them.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology